You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company said it will distribute its ExiStation MDx system and COVID-19 test kits to 20 hospitals selected by the Romanian Ministry of Public Health.
Researchers from the Human Genome Diversity Project discovered common genetic variation that is largely restricted to regions of Africa, Oceania, and the Americas.
The Economist writes that two kinds of testing are important to control the spread of COVID-19.
Nature News describes how Russia is rebuilding its scientific workforce.
In Nature this week: three-dimensional assay to visualize transposase-accessible chromatin, computational tool that uses variant information to map cells to clone of origin, and more.
The company has also submitted its ANDiS automated nucleic acid extraction system and ANDiS SARS-CoV-2 RT-qPCR detection kit to the US FDA for Emergency Use Authorization.
The Solna, Sweden-based company is currently expanding from offering in situ sequencing services to selling kits.
The Guangzhou, China-based startup has been developing a CRISPR-based diagnostic test for tuberculosis and raised $14 million in a Series A financing round last year.
The QiaStat-Dx Respiratory SARS-CoV-2 Panel can detect and differentiate SARS-CoV-2 and 21 other respiratory pathogens in symptomatic patients.
The Delaware jury said Oxford Nanopore had infringed three patents, but also found that they were invalid, mostly because they were not enabled.
The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.
Researchers have sequenced the genome of "the Methuselah of freshwater fish."
The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.
In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.